SCHEMBL14212166

SCHEMBL14212166

Cc1ccc(N(c2ccc(C)cc2)c2ccc3c(c2)Cc2cc4c(cc2-3)Cc2cc(C)ccc2-4)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP1 P53582 3/20 0.41
▸ CYP2D6 P10635 3/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MAPT P10636 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PARP10 Q53GL7 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ PARP11 Q9NR21 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14212189 0.94 CYP2C19 (0.40) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL10357231 0.93 METAP1 (0.46) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL20989424 0.93 CYP1A2 (0.41) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL14183683 0.90 CYP2C19 (0.41) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL14212177 0.89 CYP1A2 (0.50) CYP2D6CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL14212170 0.88 METAP1 (0.40) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL14183730 0.88 CYP1A2 (0.42) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL9811562 0.87 CYP1A2 (0.38) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL14183710 0.86 CYP2C19 (0.43) METAP1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL9811530 0.86 CYP2C19 (0.43) METAP1CYP2D6CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9534077-B2 Electroluminescent polymers, process for the preparation thereof, and use thereof MERCK PATENT GMBH (DE) 2017-01-03 — — US disclosed
US-20120305852-A1 ELECTROLUMINESCENT POLYMERS, PROCESS FOR THE PREPARATION THEREOF, AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120305852-A1 ELECTROLUMINESCENT POLYMERS, PROCESS FOR THE PREPARATION THEREOF, AND USE THEREOF UROD, OCIAD2, OCIAD1 METAP1 4306/4885CYP2D6 1837/4885CYP1A2 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback